Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, Inc. (RAPP), sold 10,916 shares at $26.11 ($285K) on 2026-01-20, disclosed to the SEC on 2026-01-22.
Scheduled sale ($285k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.11 | 5,083 | $133K | 46.6% |
| 2 | $26.12 | 5,833 | $152K | 53.4% |
| Total | $26.12 avg | 10,916 | $285K | 100% |
| Filing → |
| RAPP | SELL | 2026-08-26 | $938K | — | Filing → |
| RAPP | SELL | 2026-08-12 | $2.4M | — | Filing → |
| RAPP | SELL | 2026-07-29 | $93K | — | Filing → |